Table 1.
Human tumor and non-tumor cell lines used in in vitro assays.
| Cell Lines | Histology a | D.I. h (104 cell mL−1) | |
|---|---|---|---|
| Tumor cell lines | U251 b | CNS, Glioblastoma | 4.0 |
| MCF 7 b | Adenocarcinoma-mammary gland | 6.0 | |
| MCF7 BUS c | Adenocarcinoma-mammary gland | 6.0 | |
| MDA-MB-231d | Adenocarcinoma-mammary gland | 4.0 | |
| NCI-ADR/RES b, e | Adenocarcinoma-ovary | 5.0 | |
| OVCAR-3 b | Adenocarcinoma-ovary | 7.0 | |
| 786-0 b | Adenocarcinoma-kidney | 5.0 | |
| NCI-H460 b | Large Cell Carcinoma-lung | 4.0 | |
| PC-3 b | Adenocarcinoma-prostate | 4.5 | |
| HT29 b | Adenocarcinoma-colon | 5.0 | |
| Immortalized cell lines | HaCaT f | Spontaneously transformed keratinocytes from histologically normal skin | 4.0 |
| MCF 10A g | non-tumorigenic epithelial cells from mammary gland | 4.0 |
a Cell Miner (available at http://discover.nci.nih.gov/cellminer/), Cell line service (CLS) (available at http://www.clsgmbh.de/artikeldet.php?sprachnrs=2&sid=2bv11t49lt2e4s5msp8t7isho1&proid=800) and American Type Culture Collection (ATCC) (https://www.atcc.org/Products/All/CRL-10317.aspx#generalinformation); b donate by Frederick Cancer Research & Development Center, National Cancer Institute (NCI, EUA); c donate by UNESP/ Araraquara; d donate by USP/São Carlos; e multi-drug resistant cell line; f donate by FOP/UNICAMP; g donate by UNIFRAN; h D.I. = density of inoculation for anti-proliferative assay.